[spacer image]
BD
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]
[spacer image]

Healthcare-associated infections (HAIs) are a major cause of morbidity and mortality around the world. An estimated 6 million healthcare-associated infections occur each year across the United States, Europe and Japan alone.* The Centers for Disease Control and Prevention estimates there are 1.7 million infections resulting in approximately 99,000 deaths annually in the United States, making healthcare-associated infections the fourth leading cause of death.* Beyond the human toll, there is an enormous financial burden to healthcare systems worldwide. BD is committed to applying its expertise, resources and technologies toward the prevention of healthcare-associated infections worldwide.

[spacer image] News & Events

[bullet] BD Announces Agreement to Acquire HandyLab, Inc. »

[bullet] BD Adds Surveillance Capability to Infectious Disease Portfolio »

[bullet] APIC Announces Launch of Online Education Center for Instant Access to Comprehensive Infection Prevention »

[bullet] BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays  »

[bullet] BD Announces Health Canada Licensing of Novel Molecular Assay for the Detection of Vancomycin Resistance Genes »

[bullet] BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections  »

[bullet] BD Selected to Participate in Premier QUEST Nationwide Hospital Collaborative to Reduce Healthcare-Associated Infections »

[bullet] BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene  »

[bullet] BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections  »

[bullet] New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections  »

[bullet] Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU »

[bullet] BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates »

[bullet] BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures »

[bullet] BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens »

[bullet] UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent »

[bullet] CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video) »

[bullet] BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures »

[spacer image] Learn More About...

[thumbnail image] Healthcare-Associated Infections At A Glance (PDF) »

[thumbnail image] Clostridium difficile Backgrounder (PDF) »

[thumbnail image] Methicillin-Resistant Staphylococcus aureus At A Glance (PDF) »

[bullet] Active Surveillance At A Glance (PDF) »

[bullet] Emergence of MRSA Timeline (PDF) »

[bullet] HAI Terminology Guide (PDF) »

[bullet] Statistical Analysis Tools for the Fisher's Exact Test and Standardized Infection Ratio (SIR) »

[bullet] BD LabO™ Winter 2007 issue features HAIs (PDF) »

[spacer image]

[spacer image] [spacer image]

[spacer image]


[spacer image] Learn about rapid molecular solutions »
[spacer image]

[spacer image]


[spacer image] Learn about BD BBL™ CHROMagar™ MRSA »
[spacer image]

[spacer image]


[spacer image] BD is proud to support Infection Preventionists worldwide as a 2009 APIC Strategic Partner »
[spacer image]

[spacer image]

BD is a member of the Strategic Partnership program of the International Federation of Infection Control
[spacer image] BD is a member of the Strategic Partnership program of the International Federation of Infection Control
[spacer image]
[spacer image]

*Data on file at BD.
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]